Barrington raised the firm’s price target on Barrett Business (BBSI) to $45 from $41 and keeps an Outperform rating on the shares following the Q3 earnings beat. The firm expects the company’s revenue growth rates to improve in 2024 and 2025 on improved demand and strong health benefits product prospects.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.